Estimates Revisions Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.020 USD | +3.29% |
|
+7.26% | +4.80% |
| 06-30 | Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) added to Russell 2000 Value-Defensive Index | CI |
| 06-30 | Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) added to Russell 2000 Defensive Index | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- VNDA Stock
- Consensus Vanda Pharmaceuticals Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition